Ingredient or product comparison
GHK-Cu Cycling Comparison: Receptor-Mediated vs Regenerative Compounds
GHK-Cu (Copper Peptide) Tissue remodeling signaling, copper delivery, gene expression modulation No receptor downregulation observed in 8–12 week protocols Not required. Cumulative benefit increases with continuous use 12–16 weeks continuous for measurable ECM
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu (Copper Peptide)
- Tissue remodeling signaling, copper delivery, gene expression modulation
- No receptor downregulation observed in 8–12 week protocols
- Not required. Cumulative benefit increases with continuous use
- 12–16 weeks continuous for measurable ECM remodeling
- Best suited for extended uninterrupted protocols; cycling sacrifices regenerative momentum
- GHRP-6 / Ipamorelin
- Ghrelin receptor agonism triggering GH pulse
- Receptor internalization begins 10–14 days
- Required. 8–12 weeks on, 4–6 weeks off
- Maximum 12 weeks before mandatory break
- Pulsatile dosing mimics natural GH rhythm; receptor sensitivity restored during off periods
- MK-677 (Ibutamoren)
- Sustained GH/IGF-1 elevation via ghrelin mimetic
- Endogenous GH pulsatility suppression, diminishing returns after 16 weeks
- Recommended. Protocols rarely exceed 6 months
- 12–24 weeks depending on objectives
- Continuous elevation creates adaptive suppression; breaks allow HPG axis recovery
- SARMs (e.g., Ostarine)
- Selective androgen receptor binding
- HPG axis suppression, receptor saturation
- Mandatory. 8–12 weeks max, PCT required
- 8–12 weeks maximum
- Cycling prevents prolonged testosterone suppression; longer runs require medical intervention